Related articles

After treatment ends, many patients discover their body either “cannot eat” or “eats but gets no benefit”: persistent fatigue, difficulty regaining weight, muscle weakness, slow wound healing, lowered immunity, and even simple daily activities feel exhausting. This condition is medically known as “Cancer-Related Malnutrition and Metabolic Dysfunction.” It is not simply “poor appetite” or “no hunger,” but the long-term impact of chemotherapy, radiotherapy, surgery, or hormone therapy on intestinal absorption, metabolism, and mitochondrial function. Breast cancer, lung cancer, colorectal cancer, head and neck cancer, pancreatic cancer, and gastric cancer patients are particularly prone to it, and symptoms often persist for months to years — one of the most common and recovery-speed-impacting long-term side effects after treatment.

After treatment, joint stiffness, bone soreness, and reduced mobility are long-term challenges for many cancer survivors. These issues mainly result from hormonal therapies (such as aromatase inhibitors or androgen deprivation therapy), long-term corticosteroid use, or the impact of chemotherapy on bone metabolism and joint synovium. Survivors often experience morning stiffness upon waking, increased pain after activity, dull aches in the lower back or limbs, sharp pain when turning or bending, and in some cases, a higher risk of fractures or noticeable loss of height even after minor impacts.
These problems not only cause pain and mobility limitations but also increase the risk of falls, affect mood, and reduce independent living ability. Early recognition of these changes and gentle, proactive management can help maintain joint flexibility, ease bone pain, protect bone density, and gradually improve overall quality of life.

After treatment ends, nutrient supplementation and energy regulation become one of the most important long-term focuses for many cancer patients. It arises from the impact of chemotherapy, radiotherapy, hormone therapy, or the tumor itself on nutrient absorption, metabolism, and mitochondrial function. Patients often feel persistent fatigue, difficulty regaining weight, muscle weakness, lowered immunity, slow wound healing, or low mood. These issues not only affect physical strength and recovery speed but also worsen psychological stress and quality of life. Early understanding of nutritional needs and scientific supplementation strategies can help rebuild energy, support immunity and tissue repair, and allow the body and mind to gradually stabilize.

After treatment ends, nutrient supplementation and energy regulation become one of the most important long-term focuses for many cancer patients. It arises from the impact of chemotherapy, radiotherapy, hormone therapy, or the tumor itself on nutrient absorption, metabolism, and mitochondrial function. Patients often feel persistent fatigue, difficulty regaining weight, muscle weakness, lowered immunity, slow wound healing, or low mood. These issues not only affect physical strength and recovery speed but also worsen psychological stress and quality of life. Early understanding of nutritional needs and scientific supplementation strategies can help rebuild energy, support immunity and tissue repair, and allow the body and mind to gradually stabilize.

After treatment ends, decline in lung function and breathing difficulty are common long-term challenges for many cancer patients, primarily resulting from chest radiotherapy, certain chemotherapy drugs, or lung cancer surgery damaging the alveoli, airways, and lung interstitium, leading to hardened lung tissue, reduced gas exchange efficiency, and decreased lung capacity. Patients typically experience shortness of breath, chest tightness, dry cough, or pronounced breathlessness during activity. These symptoms not only affect physical stamina and endurance but also intensify fatigue, sleep issues, and anxiety. Early recognition of these changes and appropriate management can effectively help maintain lung function, improve breathing comfort, and enhance overall quality of life.

After treatment ends, joint inflammation and joint pain become a long-term issue for many patients.
They result from hormone therapy, long-term steroid use, or chemotherapy affecting the joint synovium and connective tissues.
Patients often feel joint swelling, morning stiffness, pain or heat during movement.
These problems not only limit mobility but also bring fatigue and mood effects.
Early understanding and management can help reduce inflammation and restore joint flexibility.

After treatment ends, oral mucosal damage and dry mouth are common long-term issues for many patients.
They result from chemotherapy, head and neck radiotherapy, or targeted therapy affecting the oral mucosa and salivary glands.
Patients often feel persistent dry mouth, painful swallowing, altered taste, and recurrent oral ulcers.
These problems not only affect eating and nutrition but also cause pain, infection risk, and low mood.
Early understanding and management can help restore oral comfort and appetite.

Many cancer survivors, after completing chemotherapy or head and neck radiotherapy, often find themselves wondering:
“The treatment is over, so why does everything I eat still taste off, bland, or even metallic — and why can’t I smell things properly anymore?”

Folic Acid (also known as Vitamin B9) is an indispensable nutrient in cancer treatment courses. It plays a core role in red blood cell production, DNA synthesis, and cell repair. During chemotherapy or radiotherapy, folic acid consumption is extremely high, and deficiency directly exacerbates anaemia, fatigue, and oral mucosal damage.
Many patients develop severe folic acid insufficiency due to treatment-induced intestinal absorption impairment, loss of appetite, and vomiting, which reduces treatment tolerance.
Folic acid is not an “anti-cancer vitamin” but serves as supportive care, helping patients maintain stable blood counts, energy supply, and mucosal repair under high-intensity treatment, allowing them to proceed more steadily and smoothly.

Helping you understand “how selenium can help maintain your immunity and antioxidant protection during treatment”
Selenium is an essential trace mineral that plays a critical role in cancer supportive care, as it is a key component of antioxidant enzymes (such as glutathione peroxidase), helping to reduce treatment-induced oxidative stress and inflammation.
Cancer patients often develop selenium deficiency due to treatment consumption and impaired intestinal absorption, leading to weakened immunity, increased fatigue, and greater cellular damage.
Selenium is not an “anti-cancer mineral” but serves as supportive care, helping patients better endure the burden of chemotherapy, radiotherapy, or targeted therapy, maintain tolerance, and improve overall quality of life.